It is used to treat narrowed or blocked blood vessels in the heart by reflowing blood through the blood vessels with an inflated balloon. A coronary stent is then placed into the vessel to ensure it remains open. Two types of stents are available, one that is coated with a drug to reduce the risk of future blockages (drug-eluting stents) and one that is uncoated (bare-metal stents).

The global Coronary Drug Stent System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Coronary Drug Stent System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronary Drug Stent System.

Report Scope

The Coronary Drug Stent System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Coronary Drug Stent System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Coronary Drug Stent System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Coronary Drug Stent System Market Report

Report Metric	Details
Report Name	Coronary Drug Stent System Market
CAGR	5%
Segment by Type	High Molecular Polymer Carrier No High Molecular Polymer Carrier
Segment by Application	Hospitals Clinics
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Medtronic, Boston Scientific, Biosensors, Terumo, MicroPort, Lepu Medical, B.Braun, Atrium Medical, SINOMED, LBC, Essen Technology, Yinyi Biotech CO.,LTD.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Coronary Drug Stent System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Coronary Drug Stent System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Coronary Drug Stent System Market report?

Ans: The main players in the Coronary Drug Stent System Market are Medtronic, Boston Scientific, Biosensors, Terumo, MicroPort, Lepu Medical, B.Braun, Atrium Medical, SINOMED, LBC, Essen Technology, Yinyi Biotech CO.,LTD.

What are the Application segmentation covered in the Coronary Drug Stent System Market report?

Ans: The Applications covered in the Coronary Drug Stent System Market report are Hospitals, Clinics

What are the Type segmentation covered in the Coronary Drug Stent System Market report?

Ans: The Types covered in the Coronary Drug Stent System Market report are High Molecular Polymer Carrier, No High Molecular Polymer Carrier

1 Coronary Drug Stent System Market Overview

1.1 Product Overview and Scope of Coronary Drug Stent System

1.2 Coronary Drug Stent System Segment by Type

1.2.1 Global Coronary Drug Stent System Market Value Comparison by Type (2024-2030)

1.2.2 High Molecular Polymer Carrier

1.2.3 No High Molecular Polymer Carrier

1.3 Coronary Drug Stent System Segment by Application

1.3.1 Global Coronary Drug Stent System Market Value by Application: (2024-2030)

1.3.2 Hospitals

1.3.3 Clinics

1.4 Global Coronary Drug Stent System Market Size Estimates and Forecasts

1.4.1 Global Coronary Drug Stent System Revenue 2019-2030

1.4.2 Global Coronary Drug Stent System Sales 2019-2030

1.4.3 Global Coronary Drug Stent System Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Coronary Drug Stent System Market Competition by Manufacturers

2.1 Global Coronary Drug Stent System Sales Market Share by Manufacturers (2019-2024)

2.2 Global Coronary Drug Stent System Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Coronary Drug Stent System Average Price by Manufacturers (2019-2024)

2.4 Global Coronary Drug Stent System Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Coronary Drug Stent System, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Coronary Drug Stent System, Product Type & Application

2.7 Coronary Drug Stent System Market Competitive Situation and Trends

2.7.1 Coronary Drug Stent System Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Coronary Drug Stent System Players Market Share by Revenue

2.7.3 Global Coronary Drug Stent System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Coronary Drug Stent System Retrospective Market Scenario by Region

3.1 Global Coronary Drug Stent System Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Coronary Drug Stent System Global Coronary Drug Stent System Sales by Region: 2019-2030

3.2.1 Global Coronary Drug Stent System Sales by Region: 2019-2024

3.2.2 Global Coronary Drug Stent System Sales by Region: 2025-2030

3.3 Global Coronary Drug Stent System Global Coronary Drug Stent System Revenue by Region: 2019-2030

3.3.1 Global Coronary Drug Stent System Revenue by Region: 2019-2024

3.3.2 Global Coronary Drug Stent System Revenue by Region: 2025-2030

3.4 North America Coronary Drug Stent System Market Facts & Figures by Country

3.4.1 North America Coronary Drug Stent System Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Coronary Drug Stent System Sales by Country (2019-2030)

3.4.3 North America Coronary Drug Stent System Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Coronary Drug Stent System Market Facts & Figures by Country

3.5.1 Europe Coronary Drug Stent System Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Coronary Drug Stent System Sales by Country (2019-2030)

3.5.3 Europe Coronary Drug Stent System Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Coronary Drug Stent System Market Facts & Figures by Country

3.6.1 Asia Pacific Coronary Drug Stent System Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Coronary Drug Stent System Sales by Country (2019-2030)

3.6.3 Asia Pacific Coronary Drug Stent System Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Coronary Drug Stent System Market Facts & Figures by Country

3.7.1 Latin America Coronary Drug Stent System Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Coronary Drug Stent System Sales by Country (2019-2030)

3.7.3 Latin America Coronary Drug Stent System Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Coronary Drug Stent System Market Facts & Figures by Country

3.8.1 Middle East and Africa Coronary Drug Stent System Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Coronary Drug Stent System Sales by Country (2019-2030)

3.8.3 Middle East and Africa Coronary Drug Stent System Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Coronary Drug Stent System Sales by Type (2019-2030)

4.1.1 Global Coronary Drug Stent System Sales by Type (2019-2024)

4.1.2 Global Coronary Drug Stent System Sales by Type (2025-2030)

4.1.3 Global Coronary Drug Stent System Sales Market Share by Type (2019-2030)

4.2 Global Coronary Drug Stent System Revenue by Type (2019-2030)

4.2.1 Global Coronary Drug Stent System Revenue by Type (2019-2024)

4.2.2 Global Coronary Drug Stent System Revenue by Type (2025-2030)

4.2.3 Global Coronary Drug Stent System Revenue Market Share by Type (2019-2030)

4.3 Global Coronary Drug Stent System Price by Type (2019-2030)

5 Segment by Application

5.1 Global Coronary Drug Stent System Sales by Application (2019-2030)

5.1.1 Global Coronary Drug Stent System Sales by Application (2019-2024)

5.1.2 Global Coronary Drug Stent System Sales by Application (2025-2030)

5.1.3 Global Coronary Drug Stent System Sales Market Share by Application (2019-2030)

5.2 Global Coronary Drug Stent System Revenue by Application (2019-2030)

5.2.1 Global Coronary Drug Stent System Revenue by Application (2019-2024)

5.2.2 Global Coronary Drug Stent System Revenue by Application (2025-2030)

5.2.3 Global Coronary Drug Stent System Revenue Market Share by Application (2019-2030)

5.3 Global Coronary Drug Stent System Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Medtronic

6.1.1 Medtronic Corporation Information

6.1.2 Medtronic Description and Business Overview

6.1.3 Medtronic Coronary Drug Stent System Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Medtronic Coronary Drug Stent System Product Portfolio

6.1.5 Medtronic Recent Developments/Updates

6.2 Boston Scientific

6.2.1 Boston Scientific Corporation Information

6.2.2 Boston Scientific Description and Business Overview

6.2.3 Boston Scientific Coronary Drug Stent System Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Boston Scientific Coronary Drug Stent System Product Portfolio

6.2.5 Boston Scientific Recent Developments/Updates

6.3 Biosensors

6.3.1 Biosensors Corporation Information

6.3.2 Biosensors Description and Business Overview

6.3.3 Biosensors Coronary Drug Stent System Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Biosensors Coronary Drug Stent System Product Portfolio

6.3.5 Biosensors Recent Developments/Updates

6.4 Terumo

6.4.1 Terumo Corporation Information

6.4.2 Terumo Description and Business Overview

6.4.3 Terumo Coronary Drug Stent System Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Terumo Coronary Drug Stent System Product Portfolio

6.4.5 Terumo Recent Developments/Updates

6.5 MicroPort

6.5.1 MicroPort Corporation Information

6.5.2 MicroPort Description and Business Overview

6.5.3 MicroPort Coronary Drug Stent System Sales, Revenue and Gross Margin (2019-2024)

6.5.4 MicroPort Coronary Drug Stent System Product Portfolio

6.5.5 MicroPort Recent Developments/Updates

6.6 Lepu Medical

6.6.1 Lepu Medical Corporation Information

6.6.2 Lepu Medical Description and Business Overview

6.6.3 Lepu Medical Coronary Drug Stent System Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Lepu Medical Coronary Drug Stent System Product Portfolio

6.6.5 Lepu Medical Recent Developments/Updates

6.7 B.Braun

6.6.1 B.Braun Corporation Information

6.6.2 B.Braun Description and Business Overview

6.6.3 B.Braun Coronary Drug Stent System Sales, Revenue and Gross Margin (2019-2024)

6.4.4 B.Braun Coronary Drug Stent System Product Portfolio

6.7.5 B.Braun Recent Developments/Updates

6.8 Atrium Medical

6.8.1 Atrium Medical Corporation Information

6.8.2 Atrium Medical Description and Business Overview

6.8.3 Atrium Medical Coronary Drug Stent System Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Atrium Medical Coronary Drug Stent System Product Portfolio

6.8.5 Atrium Medical Recent Developments/Updates

6.9 SINOMED

6.9.1 SINOMED Corporation Information

6.9.2 SINOMED Description and Business Overview

6.9.3 SINOMED Coronary Drug Stent System Sales, Revenue and Gross Margin (2019-2024)

6.9.4 SINOMED Coronary Drug Stent System Product Portfolio

6.9.5 SINOMED Recent Developments/Updates

6.10 LBC

6.10.1 LBC Corporation Information

6.10.2 LBC Description and Business Overview

6.10.3 LBC Coronary Drug Stent System Sales, Revenue and Gross Margin (2019-2024)

6.10.4 LBC Coronary Drug Stent System Product Portfolio

6.10.5 LBC Recent Developments/Updates

6.11 Essen Technology

6.11.1 Essen Technology Corporation Information

6.11.2 Essen Technology Coronary Drug Stent System Description and Business Overview

6.11.3 Essen Technology Coronary Drug Stent System Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Essen Technology Coronary Drug Stent System Product Portfolio

6.11.5 Essen Technology Recent Developments/Updates

6.12 Yinyi Biotech CO.,LTD.

6.12.1 Yinyi Biotech CO.,LTD. Corporation Information

6.12.2 Yinyi Biotech CO.,LTD. Coronary Drug Stent System Description and Business Overview

6.12.3 Yinyi Biotech CO.,LTD. Coronary Drug Stent System Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Yinyi Biotech CO.,LTD. Coronary Drug Stent System Product Portfolio

6.12.5 Yinyi Biotech CO.,LTD. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Coronary Drug Stent System Industry Chain Analysis

7.2 Coronary Drug Stent System Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Coronary Drug Stent System Production Mode & Process

7.4 Coronary Drug Stent System Sales and Marketing

7.4.1 Coronary Drug Stent System Sales Channels

7.4.2 Coronary Drug Stent System Distributors

7.5 Coronary Drug Stent System Customers

8 Coronary Drug Stent System Market Dynamics

8.1 Coronary Drug Stent System Industry Trends

8.2 Coronary Drug Stent System Market Drivers

8.3 Coronary Drug Stent System Market Challenges

8.4 Coronary Drug Stent System Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Yinyi Biotech CO.,LTD.

List of Tables

Table 1. Global Coronary Drug Stent System Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Coronary Drug Stent System Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Coronary Drug Stent System Market Competitive Situation by Manufacturers in 2023

Table 4. Global Coronary Drug Stent System Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Coronary Drug Stent System Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Coronary Drug Stent System Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Coronary Drug Stent System Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Coronary Drug Stent System Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Coronary Drug Stent System, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Coronary Drug Stent System, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Coronary Drug Stent System, Product Type & Application

Table 12. Global Key Manufacturers of Coronary Drug Stent System, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Coronary Drug Stent System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronary Drug Stent System as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Coronary Drug Stent System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Coronary Drug Stent System Sales by Region (2019-2024) & (K Units)

Table 18. Global Coronary Drug Stent System Sales Market Share by Region (2019-2024)

Table 19. Global Coronary Drug Stent System Sales by Region (2025-2030) & (K Units)

Table 20. Global Coronary Drug Stent System Sales Market Share by Region (2025-2030)

Table 21. Global Coronary Drug Stent System Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Coronary Drug Stent System Revenue Market Share by Region (2019-2024)

Table 23. Global Coronary Drug Stent System Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Coronary Drug Stent System Revenue Market Share by Region (2025-2030)

Table 25. North America Coronary Drug Stent System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Coronary Drug Stent System Sales by Country (2019-2024) & (K Units)

Table 27. North America Coronary Drug Stent System Sales by Country (2025-2030) & (K Units)

Table 28. North America Coronary Drug Stent System Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Coronary Drug Stent System Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Coronary Drug Stent System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Coronary Drug Stent System Sales by Country (2019-2024) & (K Units)

Table 32. Europe Coronary Drug Stent System Sales by Country (2025-2030) & (K Units)

Table 33. Europe Coronary Drug Stent System Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Coronary Drug Stent System Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Coronary Drug Stent System Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Coronary Drug Stent System Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Coronary Drug Stent System Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Coronary Drug Stent System Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Coronary Drug Stent System Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Coronary Drug Stent System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Coronary Drug Stent System Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Coronary Drug Stent System Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Coronary Drug Stent System Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Coronary Drug Stent System Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Coronary Drug Stent System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Coronary Drug Stent System Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Coronary Drug Stent System Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Coronary Drug Stent System Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Coronary Drug Stent System Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Coronary Drug Stent System Sales (K Units) by Type (2019-2024)

Table 51. Global Coronary Drug Stent System Sales (K Units) by Type (2025-2030)

Table 52. Global Coronary Drug Stent System Sales Market Share by Type (2019-2024)

Table 53. Global Coronary Drug Stent System Sales Market Share by Type (2025-2030)

Table 54. Global Coronary Drug Stent System Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Coronary Drug Stent System Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Coronary Drug Stent System Revenue Market Share by Type (2019-2024)

Table 57. Global Coronary Drug Stent System Revenue Market Share by Type (2025-2030)

Table 58. Global Coronary Drug Stent System Price (US$/Unit) by Type (2019-2024)

Table 59. Global Coronary Drug Stent System Price (US$/Unit) by Type (2025-2030)

Table 60. Global Coronary Drug Stent System Sales (K Units) by Application (2019-2024)

Table 61. Global Coronary Drug Stent System Sales (K Units) by Application (2025-2030)

Table 62. Global Coronary Drug Stent System Sales Market Share by Application (2019-2024)

Table 63. Global Coronary Drug Stent System Sales Market Share by Application (2025-2030)

Table 64. Global Coronary Drug Stent System Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Coronary Drug Stent System Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Coronary Drug Stent System Revenue Market Share by Application (2019-2024)

Table 67. Global Coronary Drug Stent System Revenue Market Share by Application (2025-2030)

Table 68. Global Coronary Drug Stent System Price (US$/Unit) by Application (2019-2024)

Table 69. Global Coronary Drug Stent System Price (US$/Unit) by Application (2025-2030)

Table 70. Medtronic Corporation Information

Table 71. Medtronic Description and Business Overview

Table 72. Medtronic Coronary Drug Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Medtronic Coronary Drug Stent System Product

Table 74. Medtronic Recent Developments/Updates

Table 75. Boston Scientific Corporation Information

Table 76. Boston Scientific Description and Business Overview

Table 77. Boston Scientific Coronary Drug Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Boston Scientific Coronary Drug Stent System Product

Table 79. Boston Scientific Recent Developments/Updates

Table 80. Biosensors Corporation Information

Table 81. Biosensors Description and Business Overview

Table 82. Biosensors Coronary Drug Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Biosensors Coronary Drug Stent System Product

Table 84. Biosensors Recent Developments/Updates

Table 85. Terumo Corporation Information

Table 86. Terumo Description and Business Overview

Table 87. Terumo Coronary Drug Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Terumo Coronary Drug Stent System Product

Table 89. Terumo Recent Developments/Updates

Table 90. MicroPort Corporation Information

Table 91. MicroPort Description and Business Overview

Table 92. MicroPort Coronary Drug Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. MicroPort Coronary Drug Stent System Product

Table 94. MicroPort Recent Developments/Updates

Table 95. Lepu Medical Corporation Information

Table 96. Lepu Medical Description and Business Overview

Table 97. Lepu Medical Coronary Drug Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Lepu Medical Coronary Drug Stent System Product

Table 99. Lepu Medical Recent Developments/Updates

Table 100. B.Braun Corporation Information

Table 101. B.Braun Description and Business Overview

Table 102. B.Braun Coronary Drug Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. B.Braun Coronary Drug Stent System Product

Table 104. B.Braun Recent Developments/Updates

Table 105. Atrium Medical Corporation Information

Table 106. Atrium Medical Description and Business Overview

Table 107. Atrium Medical Coronary Drug Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Atrium Medical Coronary Drug Stent System Product

Table 109. Atrium Medical Recent Developments/Updates

Table 110. SINOMED Corporation Information

Table 111. SINOMED Description and Business Overview

Table 112. SINOMED Coronary Drug Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. SINOMED Coronary Drug Stent System Product

Table 114. SINOMED Recent Developments/Updates

Table 115. LBC Corporation Information

Table 116. LBC Description and Business Overview

Table 117. LBC Coronary Drug Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. LBC Coronary Drug Stent System Product

Table 119. LBC Recent Developments/Updates

Table 120. Essen Technology Corporation Information

Table 121. Essen Technology Description and Business Overview

Table 122. Essen Technology Coronary Drug Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Essen Technology Coronary Drug Stent System Product

Table 124. Essen Technology Recent Developments/Updates

Table 125. Yinyi Biotech CO.,LTD. Corporation Information

Table 126. Yinyi Biotech CO.,LTD. Description and Business Overview

Table 127. Yinyi Biotech CO.,LTD. Coronary Drug Stent System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Yinyi Biotech CO.,LTD. Coronary Drug Stent System Product

Table 129. Yinyi Biotech CO.,LTD. Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Coronary Drug Stent System Distributors List

Table 133. Coronary Drug Stent System Customers List

Table 134. Coronary Drug Stent System Market Trends

Table 135. Coronary Drug Stent System Market Drivers

Table 136. Coronary Drug Stent System Market Challenges

Table 137. Coronary Drug Stent System Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Coronary Drug Stent System

Figure 2. Global Coronary Drug Stent System Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Coronary Drug Stent System Market Share by Type in 2023 & 2030

Figure 4. High Molecular Polymer Carrier Product Picture

Figure 5. No High Molecular Polymer Carrier Product Picture

Figure 6. Global Coronary Drug Stent System Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Coronary Drug Stent System Market Share by Application in 2023 & 2030

Figure 8. Hospitals

Figure 9. Clinics

Figure 10. Global Coronary Drug Stent System Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Coronary Drug Stent System Market Size (2019-2030) & (US$ Million)

Figure 12. Global Coronary Drug Stent System Sales (2019-2030) & (K Units)

Figure 13. Global Coronary Drug Stent System Average Price (US$/Unit) & (2019-2030)

Figure 14. Coronary Drug Stent System Report Years Considered

Figure 15. Coronary Drug Stent System Sales Share by Manufacturers in 2023

Figure 16. Global Coronary Drug Stent System Revenue Share by Manufacturers in 2023

Figure 17. The Global 5 and 10 Largest Coronary Drug Stent System Players: Market Share by Revenue in 2023

Figure 18. Coronary Drug Stent System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 19. Global Coronary Drug Stent System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Coronary Drug Stent System Sales Market Share by Country (2019-2030)

Figure 21. North America Coronary Drug Stent System Revenue Market Share by Country (2019-2030)

Figure 22. United States Coronary Drug Stent System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Coronary Drug Stent System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Coronary Drug Stent System Sales Market Share by Country (2019-2030)

Figure 25. Europe Coronary Drug Stent System Revenue Market Share by Country (2019-2030)

Figure 26. Germany Coronary Drug Stent System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Coronary Drug Stent System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Coronary Drug Stent System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Coronary Drug Stent System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Coronary Drug Stent System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Coronary Drug Stent System Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Coronary Drug Stent System Revenue Market Share by Region (2019-2030)

Figure 33. China Coronary Drug Stent System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Coronary Drug Stent System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Coronary Drug Stent System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Coronary Drug Stent System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Coronary Drug Stent System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. China Taiwan Coronary Drug Stent System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Coronary Drug Stent System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Latin America Coronary Drug Stent System Sales Market Share by Country (2019-2030)

Figure 41. Latin America Coronary Drug Stent System Revenue Market Share by Country (2019-2030)

Figure 42. Mexico Coronary Drug Stent System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil Coronary Drug Stent System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina Coronary Drug Stent System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Coronary Drug Stent System Sales Market Share by Country (2019-2030)

Figure 46. Middle East & Africa Coronary Drug Stent System Revenue Market Share by Country (2019-2030)

Figure 47. Turkey Coronary Drug Stent System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Coronary Drug Stent System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. UAE Coronary Drug Stent System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Global Sales Market Share of Coronary Drug Stent System by Type (2019-2030)

Figure 51. Global Revenue Market Share of Coronary Drug Stent System by Type (2019-2030)

Figure 52. Global Coronary Drug Stent System Price (US$/Unit) by Type (2019-2030)

Figure 53. Global Sales Market Share of Coronary Drug Stent System by Application (2019-2030)

Figure 54. Global Revenue Market Share of Coronary Drug Stent System by Application (2019-2030)

Figure 55. Global Coronary Drug Stent System Price (US$/Unit) by Application (2019-2030)

Figure 56. Coronary Drug Stent System Value Chain

Figure 57. Coronary Drug Stent System Production Process

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Distributors Profiles

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Blood Pressure Mointor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-35U11386

Thu Jun 20 00:00:00 UTC 2024

Add to Cart

Global Coronary Drug Stent System Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-3Z12619

Tue Jun 18 00:00:00 UTC 2024

Add to Cart

Global Implantable Cardiovascular Devices Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31Y11535

Tue Jun 18 00:00:00 UTC 2024

Add to Cart

Global Mitral Valve Interventional Devices Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36O11575

Tue Jun 18 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions